As of May 2022, a highly contagious influenza virus continues to wreak havoc on domestic bird flocks across the United States. Millions of chickens and other fowl are dying or being killed to stop the spread of an HPAI (highly
Diaclone Recombinant proteins: Human SARS-COV-2 and cytokines for immune response studies
Diaclone have developed a series of high-quality recombinant proteins, for research into Human SARS-CoV-2 and immune responses. Diaclone’s proteins are suitable for a wide range of applications, including cell culture, immunoassays, bioassays and more. These proteins are now available in
SARS-CoV-2 Antibodies from ProSci
To support the efforts of researchers worldwide in understanding and combating SARS-CoV-2, ProSci Inc has developed and manufactured COVID-19 (SARS-CoV-2, 2019-nCoV) antibodies and research reagents against the virus, and virus receptor ACE2. Polyclonal antibodies and monoclonal antibodies are available against